Patient 018 in cohort 4 had multiple sub-cm brain metastases from ERBB2-amplified and ERBB3-mutated breast cancer and was treated on study after receiving docetaxel, trastuzumab, and pertuzumab for primary and metastatic disease along with cerebellar radiation. This evidence concerns the gene ERBB3 and breast carcinoma.